Crossmark

Long-term expansion of alveolar stem cells derived from human iPS cells in organoids

Crossref DOI link: https://doi.org/10.1038/nmeth.4448

Published Online: 2017-10-02

Published Print: 2017-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yamamoto, Yuki

Gotoh, Shimpei http://orcid.org/0000-0002-8563-8200
Korogi, Yohei

Seki, Masahide

Konishi, Satoshi

Ikeo, Satoshi

Sone, Naoyuki

Nagasaki, Tadao

Matsumoto, Hisako

Muro, Shigeo

Ito, Isao

Hirai, Toyohiro

Kohno, Takashi

Suzuki, Yutaka

Mishima, Michiaki
License Information

Text and Data Mining valid from 2017-10-02
More Information

Article History

Received: 15 December 2016

Accepted: 13 August 2017

First Online: 2 October 2017

Change Date: 14 November 2017

Change Type: Correction

Change Details: In the version of this article initially published, there were errors in the Online Methods section. Specifically, incorrect concentrations were given for 8-Br-cAMP, 3-isobutyl-1-methylxanthine, and KGF, as used for induction and passage of alveolar stem cells in fibroblast-dependent organoids. The errors have been corrected in the HTML and PDF versions of the article.

Competing interests

: Kyoto University has applied for a patent related to the method of alveolar cell differentiation from induced pluripotent stem cells discussed in this paper.